Authors

    Language

    English

    Publication Date

    11-1-2025

    Journal

    Physiology

    DOI

    10.1152/physiol.00003.2025

    PMID

    40358043

    PMCID

    PMC12353178

    PubMedCentral® Posted Date

    5-13-2026

    PubMedCentral® Full Text Version

    Author MSS

    Abstract

    Ischemic heart disease, which affects more than 200 million people worldwide, is caused by reduced blood flow to the heart and leads to widespread cardiomyocyte death. Due to the limited regenerative potential of cardiomyocytes, the lost tissue is replaced by a fibrotic scar, resulting in reduced cardiac function and progression to heart failure. Current therapeutic interventions aim to improve blood flow but cannot address the inability of cardiomyocytes to renew after injury. However, multiple studies have shown that modulating the Hippo signaling pathway to activate Yes-associated protein (YAP), a transcription coactivator, in adult murine and porcine cardiomyocytes induces robust cardiomyocyte proliferation. Here, we discuss the therapeutic potential of YAP activation in the context of cardiac renewal, with a focus on both cardiomyocyte intrinsic mechanisms and the role of the microenvironment. These findings provide important insights into cardiac regeneration and strategies for developing therapies for human patients.

    Keywords

    Animals, Regeneration, Humans, Hippo Signaling Pathway, Myocytes, Cardiac, Signal Transduction, Protein Serine-Threonine Kinases, Heart, YAP-Signaling Proteins, Cell Proliferation

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.